Edges in Network
Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
Node | UBE2L6 |
Upstream (Parents) |
---|
(<<) DAZAP2 → UBE2L6 |
(<<) HLA-A → UBE2L6 |
(<<) HLA-F → UBE2L6 |
(<<) HLA-G → UBE2L6 |
(<<) INF2 → UBE2L6 |
(<<) MYO10 → UBE2L6 |
(<<) PAK6 → UBE2L6 |
(<<) PPP1R3D → UBE2L6 |
(<<) SH3GLB2 → UBE2L6 |
(<<) SPRR3 → UBE2L6 |
(<<) STAT1 → UBE2L6 |
(<<) TNFAIP3 → UBE2L6 |
Downstream (Children) |
---|
UBE2L6 → BLNK (>>) |
UBE2L6 → DDIT3 (>>) |
UBE2L6 → DUSP2 (>>) |
UBE2L6 → EIF2AK2 (>>) |
UBE2L6 → IFITM3 (>>) |
UBE2L6 → ISG20 (>>) |
UBE2L6 → KREMEN1 (>>) |
UBE2L6 → NOC3L (>>) |
UBE2L6 → PARP10 (>>) |
UBE2L6 → PKIB (>>) |
UBE2L6 → RHOD (>>) |
UBE2L6 → SOCS1 (>>) |